REFERENCES
- Faigle J. W. Drug metabolism in the colon wall and lumen. Colonic Drug Absorption and Metabolism, P. R. Bieck. Informa UK Ltd, New York 1993; 29–54
- Friedman S., Blumberg R. S. Inflammatory bowel disease. Harrison's Principles of Internal Medicine16th, D. L. Kasper, et al. Informa UK Ltd, New York 2004
- Friend D. R. Colon-specific drug delivery. Advanced Drug Delivery Reviews 1991; 7: 149–199, [CSA]
- Friend D. R., Chang G. W. Drug glycosides: potential prodrugs for colon-specific drug delivery. J. Med. Chem. 1985; 28: 51–57, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Friend D. R., Chang G. W. A colon-specific drug-delivery system based on drug glycosides and the glycosidases of colonic bacteria. J. Med. Chem. 1984; 27: 261–266, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Haeberline B., Rubas W., Nolen H. W. III, Friend D. R. In vitro evaluation of dexamethasone-β-D-glucuronide for colon-specific drug delivey. Pharm. Res. 1993; 10: 1553–1562, [CSA], [CROSSREF]
- Huijghebaert S., Sim S. M., Back D. J., Eyssen H. J. Distribution of estrone sulfatase activity in the intestine of germ-free and conventional rats. Steroid Biochem. 1984; 20: 1175–1179, [CSA], [CROSSREF]
- Jung Y. J., Doh M. J., Kim I. H., Kong H. S., Lee J. S., Kim Y. M. Prednisolone 21-sulfate sodium: a colon-specific pro-drug of prednisolone. J. Pharm. Pharmcol. 2003; 55: 1075–1082, [CSA], [CROSSREF]
- McLeod A. D., Friend D. R., Tozer T. N. Glucocorticoid-dextran conjugate as potential prodrugs for colon-specific delivery: hydrolysis in rat gastrointestinal tract contents. J. Pharm. Sci. 1994; 83: 1284–1288, [PUBMED], [INFOTRIEVE], [CSA]
- McLeod A. D., Friend D. R., Tozer T. N. Synthesis and chemical stability of glucocorticoid-dextran ester: potential prodrugs for colon-specific delivery. Int. J. Pharm. 1993; 92: 105–114, [CSA], [CROSSREF]
- Morris G. P., Beck P. L., Herridge M. S., Depew W. T., Szewczuk M. R., Wallace J. L. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96: 795–803, [PUBMED], [INFOTRIEVE], [CSA]
- Nolen H., III, Fedorak R. N., Friend D. R. Budesonide-β-D-glucuronide: a potential prodrug for treatment of ulcerative colitis. J. Pharm. Sci. 1995; 84: 677–681, [PUBMED], [INFOTRIEVE], [CSA]
- Robinson M. Medical therapy of inflammatory bowel disease for the 21st century. Eur. J. Surg. Suppl. 1998; 582: 90–98, [PUBMED], [INFOTRIEVE], [CSA]
- Rubinstein A. Microbially controlled drug delivery to the colon. Biopharm. & Drug Disposition 1990; 11: 465–475, [INFOTRIEVE], [CSA]
- Schimmer B. P., Parker K. L. Adrenocorticotropic Hormone; Adrenocortical steroids and their synthetic analogs; Inhibitors of the synthesis and actions of adrenocortical hormones. Goodman and Gilman's The Pharmacological Basis of Therapeutics10th, J. G. Hardman, L. E. Limbird. Informa UK Ltd, New York 2001; 1649–1678
- Shamat M. A. The role of the gastrointestinal microflora in the metabolism of drugs. Int. J. Pharm. 1993; 97: 1–13, [CSA], [CROSSREF]
- Sinha V. R., Kumria R. Microbially triggered drug delivery to the colon. Europ. J. Pharm. Sci. 2003; 18: 3–18, [CSA], [CROSSREF]
- Van Eldere J., Robben J., De Pauw G., Merckx R., Eyssen H. Isolation and identification of intestinal steroid-desulfating bacteria from rats and humans. Appl. Evirn. Microbiol. 1994; 54: 2112–2117, [CSA]
- William-Smith H. Observations on the flora of the alimentary tract of animals and factors affecting its composition. J. Pathol. Bacteriol. 1965; 89: 95–122, [CSA], [CROSSREF]
- Yano H., Hirayama F., Arima H., Uekma K. Prednisolone-appended α-cyclodextrin: alleviation of systemic adverse effect of prednisolone after intracolonic administration in 2, 4, 6-trinitrobenzensulfonic acid-induced colitis rats. J. Pharm. Sci. 2001; 90: 2103–2112, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]